HELP     Sign In
Search

Relevance to Autism

Rare variants in the EIF4E gene have been identified with autism (Neves-Pereira et al., 2009).

Molecular Function

Translation initiation factor involved in directing ribosomes to the cap structure of mRNAs

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Deregulation of EIF4E: a novel mechanism for autism.
ASD
Positive Association
Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range.
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
Genome-wide characteristics of de novo mutations in autism
ASD
Support
High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism.
Non-syndromic ASD
Highly Cited
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.
Highly Cited
The translational repressor Pumilio regulates presynaptic morphology and controls postsynaptic accumulation of translation factor eIF-4E.
Highly Cited
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.
Highly Cited
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
Highly Cited
The mRNA 5' cap-binding protein eIF4E and control of cell growth.
Recent Recommendation
Exaggerated translation causes synaptic and behavioural aberrations associated with autism.
Recent Recommendation
Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning...
Recent Recommendation
eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN077R001 
 translocation 
  
  
 De novo 
  
 Simplex 
 GEN077R002 
 2KB_upstream_variant 
 c.-25insC 
  
 Familial 
 Paternal 
 Multiplex 
 GEN077R003 
 2KB_upstream_variant 
 c.-25insC 
  
 Familial 
 Paternal 
 Multiplex 
 GEN077R004 
 intron_variant 
 c.540-10T>G 
  
  
  
 Multiplex 
 GEN077R005 
 missense_variant 
 c.194A>T 
 p.Lys65Met 
 De novo 
  
 Simplex 
 GEN077R006 
 missense_variant 
 c.272A>G 
 p.Tyr91Cys 
 De novo 
  
  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN077C001 
 intron_variant 
 rs13109000 
 c.186-3048A>G;c.126-3048A>G;c.210-3048A>G 
  
 708 German ASD families; 605 individuals diagnosed with strict autism, subgroup of 369 individuals in high-functioning strict autism range (HFA) 
 Discovery 
 GEN077C002 
 intron_variant 
 rs4699369 
 c.282-319C>T;c.222-319C>T;c.306-319C>T 
  
 708 German ASD families; 605 individuals diagnosed with strict autism, subgroup of 369 individuals in high-functioning strict autism range (HFA) 
 Discovery 
 GEN077C003 
 intron_variant 
 rs12498533 
 c.185+4194T>G;c.125+4194T>G;c.209+4194T>G 
  
 708 German ASD families; 605 individuals diagnosed with strict autism, subgroup of 369 individuals in high-functioning strict autism range (HFA) 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 1
 
4
Deletion-Duplication
 13
 
4
Deletion-Duplication
 2
 
4
Duplication
 1
 
4
Deletion-Duplication
 12
 

Model Summary

The EIF4E transgenic mouse shows increased cap-dependent translation, synaptic abnormalities in the medial prefrontal cortex, striatum, and hippocampus, repetitive behaviors and deficits in social interactions. The cap-dependent translation inhibitor, 4EGI-1, rescues repetitive behaviors and deficits in social interactions in the EIF4E transgenic mutant mice.

References

Type
Title
Author, Year
Primary
Exaggerated translation causes synaptic and behavioural aberrations associated with autism.
Additional
Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations

M_EIF4E_1_TG

Model Type: Genetic
Model Genotype: Other
Mutation: Transgenic mice were generated using a minigene cassette consisting of the human EIF4E cDNA, the ubiquitous human actin promoter, and the SV40 polyadenylation site. eIF4E transgenic mice show increased expression of eIF4E in multiple brain regions including the prefrontal cortex, striatum, hippocampus and cerebral cortex.
Allele Type: Overexpression (Transgenic)
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_EIF4E_2_COE-MGL

Model Type: Genetic
Model Genotype: Other
Mutation: Cx3cr1^CreER/+;Rosa26^Ai9/+ mice mice with conditional overexpression of translation initiation factor eIF4E allele at the Rosa26 locus, inserted between exons 1 and 2, that expresses Myc-tagged eIF4E (R26Eif4e) in a Cre-dependent manner in microglia (using Cx3cr1^CreER, Jackson Laboratories stock no. 021160). One tamoxifen injection (180 mg/kg, s.c.) was administered to Cx3cr1^CreER/+;Rosa26^Ai9/+ mice at P0 to activate CreER to excise the loxP-flanked transcription blocker of the Rosa26Ai9 allele in microglia, leading to tdTomato expression. CD68-EGFP transgene reporter is used to assay microglial migration.
Allele Type: Overexpression (Transgenic)
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: NA

M_EIF4E_3_COE-NEU

Model Type: Genetic
Model Genotype: Other
Mutation: Mice with conditional overexpression of translation initiation factor eIF4E allele at the Rosa26 locus, inserted between exons 1 and 2, that expresses Myc-tagged eIF4E (R26Eif4e) in a Cre-dependent manner in neurons (using Syn1-Cre, Jackson Laboratories stock no. 003966), from embryonic day 12.5 onwards. (Syn1-Cre;R26^Eif4e/Eif4e, NN^4E).
Allele Type: Overexpression (Transgenic)
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: NA

M_EIF4E_4_COE-AST

Model Type: Genetic
Model Genotype: Other
Mutation: Mice with conditional overexpression of translation initiation factor eIF4E allele at the Rosa26 locus, inserted between exons 1 and 2, that expresses Myc-tagged eIF4E (R26Eif4e) in a Cre-dependent manner in astrocytes, using GFAP-Cre (Jackson Laboratories stock no. 024098) which becomes active during late embryogenesis and the first postnatal week (GFAP-Cre;R26^Eif4e/Eif4e)
Allele Type: Overexpression (Transgenic)
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line: NA
Mutant ES Cell Line: NA
Model Source: NA

M_EIF4E_1_TG

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Hyperactivity1
Increased
Description: Eif4e transgenic mice show slight increase in total time spent moving and total distance travelled compared to controls
Exp Paradigm: Males only
 Partition test
 26 months
General locomotor activity: ambulatory activity1
Increased
Description: Eif4e transgenic mice show slight increase in total time spent moving and total distance travelled compared to controls
Exp Paradigm: Males only
 Partition test
 26 months
Dendritic architecture: spine density1
Increased
Description: Eif4e transgenic mice show increased dendritic spine density and a smaller spine volume compared to controls
Exp Paradigm: Dendritic spines were imaged using two-photon laser-scanning microscopy. males only.
 Immunohistochemistry
 26 months
Spontaneous post synaptic event amplitude: inhibitory currents1
Increased
Description: Eif4e transgenic mice show an increase in the amplitude, but not frequency, of inhibitory mipsc events in layers ii/iii of acute mpfc slices, compared to controls. no changes were observed in layer v.
Exp Paradigm: Males only
 Whole-cell patch clamp
 26 months
Synaptic plasticity: striatal ltd1
Increased
Description: Eif4e transgenic mice exhibited enhanced ltd compared to wild-type littermates
Exp Paradigm: Males only
 Whole-cell patch clamp
 26 months
Synaptic plasticity: hippocampal ltd1
Increased
Description: Eif4e transgenic mice exhibited enhanced mglur-ltd compared to wild-type littermates
Exp Paradigm: Males only
 Whole-cell patch clamp
 26 months
Spontaneous post synaptic event frequency: excitatory currents1
Increased
Description: Eif4e transgenic mice show an increase in the frequency but not amplitude of spontaneous synaptic excitatory mepsc events in layers ii/iii of acute mpfc slices, compared to controls. no changes were observed in layer v.
Exp Paradigm: Males only
 Whole-cell patch clamp
 26 months
Self grooming: perseveration1
Increased
Description: Eif4e transgenic mice show increased self-grroming compared to controls
Exp Paradigm: Males only
 Grooming behavior assessments
 26 months
Repetitive digging1
Increased
Description: Eif4e transgenic mice exhibited repetitive digging behavior in the marble burying test unlike control mice
Exp Paradigm: Males only
 Marble-burying test
 26 months
Social approach1
Decreased
Description: Eif4e transgenic mice show reduced preference for a novel stranger compared to a novel inanimate object, compared to controls
Exp Paradigm: Males only.
 Three-chamber social approach test
 26 months
Inanimate object preference1
Increased
Description: Eif4e transgenic mice show preference for a novel inanimate object over a stranger mouse, compared to controls
Exp Paradigm: Novel object interaction test. males only.
 Novel object recognition test
 26 months
Social interaction1
Decreased
Description: Eif4e transgenic mice exhibited diminished reciprocal interactions with a freely moving stranger mouse, compared to controls
Exp Paradigm: Males only.
 Three-chamber social approach test
 26 months
Cognitive flexibility1
Decreased
Description: Eif4e transgenic mice exhibited cognitive inflexibility in being impaired in locating the new platform positions compared to control mice
Exp Paradigm: Males only-water y-maze
 Water y-maze test
 26 months
Cognitive flexibility1
Decreased
Description: Eif4e transgenic mice exhibited cognitive inflexibility in being impaired in locating the new platform positions compared to control mice
Exp Paradigm: Males only- morris water maze test
 Morris water maze test
 26 months
Cued or contextual fear conditioning: extinction1
Decreased
Description: Eif4e transgenic mice did not exhibit a significant reduction in freezing responses following extinction training as did control mice
Exp Paradigm: Males only
 Fear conditioning test
 26 months
Targeted expression1
Increased
Description: Eif4e transgenic mice show increased expression of eif4e in multiple brain regions including the prefrontal cortex, striatum, hippocampus and cerebral cortex, compared to controls
Exp Paradigm: Males only
 Western blot
 26 months
Regulation of translation1
Decreased
Description: Eif4e transgenic mice show increased de novo cap-dependent translation in the brain, compared to controls
Exp Paradigm: Puromycin was infused into the lateral ventricle of cannulated mice and newly synthesized proteins were labeled using sunset and de novo cap-dependent translation was observed. males only.
 Autoradiographic analysis
 26 months
Protein binding1
Increased
Description: Eif4e transgenic mice show increased binding of eif4e to eif4g in the brain, compared to controls
Exp Paradigm: Transgenic brain tissue was used as sample. males only.
 Immunoprecipitation
 26 months
General characteristics1
 No change
 General observations
 26 months
Mortality/lethality1
 No change
 General observations
 P0
Anxiety1
 No change
 Elevated plus maze test
 26 months
Spatial learning1
 No change
 Morris water maze test
 26 months
Spatial learning1
 No change
 Water y-maze test
 26 months
Spatial reference memory1
 No change
 Morris water maze test
 26 months
Spatial reference memory1
 No change
 Water y-maze test
 26 months
Gene expression1
 No change
 Semi-quantitative pcr (qrt-pcr)
 26 months
Protein binding1
 No change
 Western blot
 26 months
Grip strength1
 No change
 Accelerating rotarod test
 26 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 26 months
Swimming ability1
 No change
 Morris water maze test
 26 months
Swimming ability1
 No change
 Water y-maze test
 26 months
Spontaneous post synaptic event amplitude: excitatory currents1
 No change
 Whole-cell patch clamp
 26 months
Spontaneous post synaptic event frequency: inhibitory currents1
 No change
 Whole-cell patch clamp
 26 months
Reproductive function1
 No change
 General observations
 26 months
Vertical jumping or back flipping1
 No change
 Partition test
 26 months
Sensorimotor gating1
 No change
 Prepulse inhibition
 26 months
Startle response: acoustic stimulus1
 No change
 Acoustic startle reflex test
 26 months
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Physiological parameters, Seizure

M_EIF4E_2_COE-MGL

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Microglial number1
Increased
Description: Increase in microglia numbers in the mpfc, hip and str at 2 weeks; decrease in microglial numbers in the str at 6 weeks; no change in microglial density in the in the mpfc and hip at 6 weeks
Exp Paradigm: Iba1
 Immunohistochemistry
 2 weeks, 6 weeks
Dendritic architecture: spine density1
Increased
Description: Higher spine density in mpfc at 6 weeks, increased spine density in pyramidal neurons of mpfc layer 5 and hippocampal ca1 at 2 and 6 weeks male but not female mice
Exp Paradigm: NA
 Scanning electron microscopy
 6 weeks
Microglial morphology1
Increased
Description: Increase in size and complexity of microglia in mpfc
Exp Paradigm: Iba1
 Histomorphometry
 2 weeks
Synapse density: excitatory1
Decreased
Description: More asymmetric (excitatory) synapses in the prl of 6-week-old male, but not female,
Exp Paradigm: NA
 Scanning electron microscopy
 6 weeks
Microglial morphology1
Increased
Description: Increase in microglial size in the mpfc, hip, str
Exp Paradigm: Iba1
 Immunohistochemistry
 2 weeks, 6 weeks
Post-synaptic density size1
Decreased
Description: Decreased psd surface area
Exp Paradigm: NA
 Scanning electron microscopy
 6 weeks
Dendritic architecture: spine morphology1
Decreased
Description: Decreased spine volume
Exp Paradigm: NA
 Scanning electron microscopy
 6 weeks
Neuron remodeling: dendritic pruning1
Decreased
Description: Decreased postsynaptic proteins in microglia
Exp Paradigm: Homer1, iba1
 Immunofluorescence staining
 P14-p18
Microglial migration1
Decreased
Description: Decreased in number of microglia that migrate to the injection site
Exp Paradigm: NA
 Confocal microscopy
 2 weeks
Miniature post synaptic current amplitude: inhibitory1
Decreased
Description: Increased mipsc amplitude
Exp Paradigm: NA
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current amplitude: excitatory1
Increased
Description: Increased mepsc amplitude
Exp Paradigm: NA
 Whole-cell patch clamp
 6-7 weeks
Synaptic transmission1
Increased
Description: Increased total charge transfer in mepscs than for mipscs
Exp Paradigm: NA
 Whole-cell patch clamp
 6-7 weeks
Microglial migration: induced1
Decreased
Description: Decreased atp induced motility
Exp Paradigm: NA
 Immunofluorescence staining
 P14-p18
Self grooming: perseveration1
Increased
Description: Increased time spent self-grooming
Exp Paradigm: NA
 Grooming behavior assessments
 2-3 months
Social approach1
Decreased
Description: Decreased preference for a social versus inanimate stimulus
Exp Paradigm: NA
 Three-chamber social approach test
 2-3 months
Social memory1
Decreased
Description: Decreased preference for an unfamiliar versus a familiar social stimulus
Exp Paradigm: NA
 Home cage behavior
 2-3 months
Social habituation1
Decreased
Description: Decreased time spent in novel social investigation in trial 4 versus trial 1
Exp Paradigm: NA
 Home cage behavior
 2-3 months
Social dishabituation1
Decreased
Description: Decreased time spent investigating a novel mouse versus a mouse in the 4th trial
Exp Paradigm: NA
 Home cage behavior
 2-3 months
Innate immune response1
Increased
Description: Increased phagocytosis
Exp Paradigm: NA
 Immunofluorescence staining
 2 weeks
Object recognition memory1
Decreased
Description: Decreased time spent investigating a novel object
Exp Paradigm: NA
 Novel object recognition test
 2-3 months
Targeted expression1
Increased
Description: Increased expression of tdtomato marker in iba1 positive microglia
Exp Paradigm: NA
 Immunofluorescence staining
 P14
Gene expression: autoimmune thyroid disease pathways1
Increased
Description: Upregulation of genes associated with autoimmune thyroid disease pathways, implicated in asd; no change of transcript level is seen at 6 weeks
Exp Paradigm: NA
 Rna sequencing
 2 weeks, 6 weeks
Gene expression: neurodegeneration1
Increased
Description: Upregulation of disease associated microglial genes; no change of transcript level is seen at 6 weeks
Exp Paradigm: NA
 Rna sequencing
 2 weeks, 6 weeks
Gene expression: activated microglia1
Increased
Description: Upregulation of very few genes associated with polarized microglial states m1 (proinflammatory) and m2 (anti-inflammatory)
Exp Paradigm: NA
 Rna sequencing
 2 weeks, 6 weeks
Targeted expression1
Increased
Description: Increased microglial eif4e protein levels
Exp Paradigm: NA
 Immunohistochemistry
 P14
Gene expression: leukocyte mobility1
Decreased
Description: Downregulation of transcripts including markers for homeostatic microglia such as p2ry12, p2ry13, cx3cr1, tmem119, and slco2b1 associated with leukocyte cellcell adhesion, leukocyte migration, and cellcell adhesion
Exp Paradigm: NA
 Rna sequencing
 2 weeks
Differential gene expression1
Abnormal
Description: Abnormal transcript levels of genes (sra accession number prjna609402)
Exp Paradigm: NA
 Rna sequencing
 2 weeks, 6 weeks
Targeted expression1
Increased
Description: Increased levels of total eif4e and eif4e-myc protein in the hippocampus
Exp Paradigm: NA
 Western blot
 Adult
Gene expression: herpes simplex virus infection1
Increased
Description: Upregulation of genes associated with antimicrobial activity in the kegg pathway including pathways responding to herpes simplex infection, implicated in asd; no change of transcript level is seen at 6 weeks
Exp Paradigm: NA
 Rna sequencing
 2 weeks, 6 weeks
Cell adhesion1
Increased
Description: Increased protein levels of neuroligins 1 and 2 in the hippocampus and mpfc in male, but not female
Exp Paradigm: NA
 Western blot
 6 weeks
Anxiety1
 No change
 Elevated plus maze test
 2-3 months
Anxiety1
 No change
 Open field test
 2-3 months
Anxiety1
 No change
 Light-dark exploration test
 2-3 months
Innate immune response1
 No change
 Immunofluorescence staining
 2 weeks
Cued or contextual fear conditioning: memory of context1
 No change
 Fear conditioning test
 2-3 months
Object recognition memory1
 No change
 Novel object recognition test
 2-3 months
Cell adhesion1
 No change
 Quantitative pcr (qrt-pcr)
 6 weeks
Protein expression level evidence1
 No change
 Western blot
 Adult
Protein expression level evidence1
 No change
 Western blot
 6 weeks
General locomotor activity: ambulatory activity1
 No change
 Open field test
 2-3 months
Microglial morphology1
 No change
 Immunohistochemistry
 2 weeks, 6 weeks
Microglial number1
 No change
 Immunohistochemistry
 2 weeks, 6 weeks
Neuroreceptor levels: glutamate receptors: ampa receptors1
 No change
 Western blot
 6 weeks
Synapse density: excitatory1
 No change
 Scanning electron microscopy
 6 weeks
Synapse density: inhibitory1
 No change
 Scanning electron microscopy
 6 weeks
Synapse density: mature boutons1
 No change
 Scanning electron microscopy
 6 weeks
Microglial migration1
 No change
 Confocal microscopy
 2 weeks
Microglial migration: baseline1
 No change
 Immunofluorescence staining
 P14-p18
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Neuron remodeling: dendritic pruning1
 No change
 Immunofluorescence staining
 P14-p18
Synaptic transmission1
 No change
 Whole-cell patch clamp
 6-7 weeks
Cellular motility: induced1
 No change
 Immunofluorescence staining
 P14-p18
Repetitive digging1
 No change
 Marble-burying test
 2-3 months
Self grooming: perseveration1
 No change
 Grooming behavior assessments
 2-3 months
Social approach1
 No change
 Three-chamber social approach test
 2-3 months
Social dishabituation1
 No change
 Home cage behavior
 2-3 months
Social habituation1
 No change
 Home cage behavior
 2-3 months
 Not Reported:

M_EIF4E_3_COE-NEU

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Repetitive digging1
Increased
Description: Increase in number of marbles buried
Exp Paradigm: NA
 Marble-burying test
 2 months
Anxiety1
Increased
Description: Increased time spent in the closed arms
Exp Paradigm: NA
 Elevated plus maze test
 2 months
Anxiety1
Increased
Description: Decreased time spent in the center
Exp Paradigm: NA
 Open field test
 2 months
Cued or contextual fear conditioning: memory of context1
Increased
Description: Increased freezing in the contextual chamber 24 h after fear condition training
Exp Paradigm: NA
 Fear conditioning test
 2 months
Targeted expression1
Increased
Description: Increased levels of total eif4e and eif4e-myc protein in the hippocampus
Exp Paradigm: NA
 Western blot
 Adult
Regulation of translation1
Increased
Description: Increased rate of protein synthesis
Exp Paradigm: NA
 Western blot
 Adult
Protein expression level evidence1
Decreased
Description: Decreased levels of endogenous eif4e protein
Exp Paradigm: NA
 Western blot
 Adult
Anxiety1
 No change
 Elevated plus maze test
 2 months
Anxiety1
 No change
 Light-dark exploration test
 2 months
Spatial working memory1
 No change
 T-maze test
 2 months
Protein expression level evidence1
 No change
 Western blot
 6 weeks
General locomotor activity: ambulatory activity1
 No change
 Open field test
 2 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 2 months
Repetitive digging1
 No change
 Marble-burying test
 2 months
Social approach1
 No change
 Three-chamber social approach test
 2 months
 Not Reported:

M_EIF4E_4_COE-AST

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Regulation of translation1
Increased
Description: Increased rate of protein synthesis
Exp Paradigm: NA
 Western blot
 Adult
Protein expression level evidence1
Decreased
Description: Decreased endogenous eif4e protein levels
Exp Paradigm: NA
 Western blot
 Adult
Targeted expression1
Increased
Description: Increased levels of total eif4e and eif4e-myc protein in the hippocampus
Exp Paradigm: NA
 Western blot
 Adult
Repetitive digging1
 No change
 Marble-burying test
 2 months
Social approach1
 No change
 Three-chamber social approach test
 2 months
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ANGEL1 angel homolog 1 (Drosophila) 23357 Q9UNK9 IP; LC-MS/MS
Huttlin EL , et al. 2015
CHD8 chromodomain helicase DNA binding protein 8 57680 Q9HCK8 ChIP-chip
Subtil-Rodrguez A , et al. 2013
DDX6 DEAD (Asp-Glu-Ala-Asp) box helicase 6 1656 P26196 IP/WB; in vitro binding assay
Wang Y , et al. 2015
EIF3B eukaryotic translation initiation factor 3, subunit B 8662 P55884 IP/WB
Harris TE , et al. 2006
EIF3F eukaryotic translation initiation factor 3, subunit F 8665 O00303 IP; MS; COMPASS
Sowa ME , et al. 2009
EIF4A1 eukaryotic translation initiation factor 4A1 1973 P60842 Affinity chromatography
Connolly E , et al. 2006
EIF4A1 eukaryotic translation initiation factor 4A1 1973 P60842 IP; LC-MS/MS
Huttlin EL , et al. 2015
EIF4A2 eukaryotic translation initiation factor 4A2 1974 Q14240 IP; MS
Ewing RM , et al. 2007
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 1978 Q13541 Y2H
Corominas R , et al. 2014
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 1978 Q13541 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 1978 Q13541 IP; LC-MS/MS
Huttlin EL , et al. 2015
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 1978 Q13541 GST
Mader S , et al. 1995
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 1979 Q13542 Y2H
Corominas R , et al. 2014
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 1979 Q13542 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 1979 Q13542 ITC; NMR spectroscopy
Bah A , et al. 2014
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 1979 Q13542 IP; LC-MS/MS
Huttlin EL , et al. 2015
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 1979 Q13542 GST
Mader S , et al. 1995
EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3 8637 O60516 Y2H
Corominas R , et al. 2014
EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3 8637 O60516 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3 8637 O60516 Affinity chromatography; IP/WB
Poulin F , et al. 1998
EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 56478 Q9NRA8 Affinity chromatography; IP/WB
Dostie J , et al. 2000
EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 56478 Q9NRA8 Y2H
Corominas R , et al. 2014
EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 56478 Q9NRA8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 56478 Q9NRA8 BioID
Nishimura T , et al. 2015
EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 56478 Q9NRA8 IP; LC-MS/MS
Huttlin EL , et al. 2015
EIF4G1 eukaryotic translation initiation factor 4 gamma, 1 1981 Q04637 IP; LC-MS/MS
Huttlin EL , et al. 2015
EIF4G1 eukaryotic translation initiation factor 4 gamma, 1 1981 Q04637 GST; IP/WB
Mader S , et al. 1995
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 1982 P78344 GST; IP/WB
Gradi A , et al. 1998
KANK2 KN motif and ankyrin repeat domains 2 25959 Q63ZY3 Y2H
Corominas R , et al. 2014
KANK2 KN motif and ankyrin repeat domains 2 25959 Q63ZY3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MKNK1 MAP kinase interacting serine/threonine kinase 1 8569 Q9BUB5 IP/WB; Metabolic labeling with 32P
Pyronnet S , et al. 1999
PML promyelocytic leukemia 5371 P29590 GST
Cohen N , et al. 2001
STUB1 STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase 10273 Q9UNE7 IP/WB
Murata T and Shimotohno K 2006
TDO2 tryptophan 2,3-dioxygenase 6999 P48775 Y2H
Corominas R , et al. 2014
TDO2 tryptophan 2,3-dioxygenase 6999 P48775 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TRIM27 tripartite motif-containing 27 5987 P14373 Y2H
Corominas R , et al. 2014
TRIM27 tripartite motif-containing 27 5987 P14373 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
UBXN11 UBX domain protein 11 91544 Q5T124 Y2H
Corominas R , et al. 2014
UBXN11 UBX domain protein 11 91544 Q5T124 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
YBX1 Y box binding protein 1 4904 P67809 IP/WB; in vitro binding assay
Wang Y , et al. 2015
CYFIP1 Cytoplasmic FMR1-interacting protein 1 20430 Q7TMB8 GST; IP/WB
Napoli I , et al. 2008
FMR1 fragile X mental retardation 1 14265 P35922 IP/WB
Napoli I , et al. 2008
park park 40336 Q7KTX7 GST
Ottone C , et al. 2010

HELP
Copyright © 2017 MindSpec, Inc.